|
Support 2006 |
The EPF acknowledges
gratefully the support in 2006, in the form of unrestricted grants from:
| BAXTER: 30,000 EUR |
| BMS: 10,000 EUR |
| GSK: 35,000 EUR |
| NOVARTIS: 50,000 EUR |
| PHARMA: 50,000 EUR |
| PFIZER: 50,000 EUR |
| MSD: 40,000 EUR |
| UCB: 30,000 EUR |
| Further unrestricted grants were received in 2006 from Pfizer and GSK to contribute towards the organisation of the EPF Spring Conference in early 2007. |
